Skip to content

Evidence of Good Glycemic control in Conceptions through Assisted Reproduction Technology [EGG CART Study]

A Prospective, Monocentric, Open labelled, Multiple arm study on the influence of strict periconception glycemic control in women with various degrees of glucose intolerance in the setting of conceptions through Assisted Reproduction Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2008/091/000179
Enrollment
300
Registered
2008-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Women with Prediabetes and Diabetes prior to conception through Assisted Reproduction Technology

Interventions

Intervention1: Insulin Aspart before major meals &amp
NPH at bedtime if required: Multiple doses of insulin with dose titrations at regular intervals to maintain near-normoglycemia till delivery Control Intervention1: Nil: Controls will be normoglycemic
will receive routine antenatal care

Sponsors

DrSNallaperumal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age up to 45 years, failure to conceive after at least 1 year of unprotected sex, Use of self or donor egg for fertilization, Both IVF naive and repeaters [up to 4 attempts], OGTT normal for normoglycemic arm, OGTT [FBS 101 to 125 mg/dl, 2 hour PPBS 141 to 199 mg/dl] for prediabetic arm, OGTT [FBS > 126 mg/dl, 2 hour PPBS > 200 mg/dl] for diabetics

Exclusion criteria

Exclusion criteria: Male factor infertility [Azoospermia], Impaired fertility caused by endocrine dysfunction other than diabetes mellitus, Smokers, Alcohol and other illicit drug abusers, other medical conditions which contraindicate treatment with Assisted Reproduction Technology

Design outcomes

Primary

MeasureTime frame
Adverse pregnancy outcomes (congenital abnormalities, Neonatal Hypoglycemia, LGA, SGA, Spontaneous abortions, Stillbirth, neonatal death) in diabetic and prediabetic womenTimepoint: Neonatal Hypoglycemia - From birth to 48 hours. All other outcomes at the time of delivery

Secondary

MeasureTime frame
Conception rateTimepoint: 10 weeks from the date of embryo transfer [excludes biochemical pregnancy]

Countries

India

Contacts

Public ContactDr.S.Nallaperumal
swamydiabetes@gmail.com04428363513

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026